论文信息 - Rosuvastatin Is Effective to Decrease CD8 T-Cell Activation Only in HIV-Infected Patients With High Residual T-Cell Activation Under Antiretroviral Therapy - 字舞流文

Rosuvastatin Is Effective to Decrease CD8 T-Cell Activation Only in HIV-Infected Patients With High Residual T-Cell Activation Under Antiretroviral Therapy

D. Costagliola | M. Alhenc-Gelas | C. Didier | P. Girard | L. Weiss | L. Assoumou | P. Campa | M. Chevalier | J. Paul | Saïd Taibi | E. Manea | M. Alhenc‐Gelas | Jean-Louis Paul